| MSC therapies for COVID-19: importance of patient coagulopathy, thromboprophylaxis, cell product quality and mode of delivery for treatment safety and efficacy G Moll, N Drzeniek, J Kamhieh-Milz, S Geissler, HD Volk, P Reinke Frontiers in immunology 11, 550154, 2020 | 159 | 2020 |
| Bio-instructive hydrogel expands the paracrine potency of mesenchymal stem cells NM Drzeniek, A Mazzocchi, S Schlickeiser, SD Forsythe, G Moll, S Geißler, ... Biofabrication 13 (4), 045002, 2021 | 37 | 2021 |
| Implantable biomaterials for peripheral nerve regeneration–technology trends and translational tribulations A Sanchez Rezza, Y Kulahci, VS Gorantla, F Zor, NM Drzeniek Frontiers in Bioengineering and Biotechnology 10, 863969, 2022 | 16 | 2022 |
| Immuno-engineered mRNA combined with cell adhesive niche for synergistic modulation of the MSC secretome NM Drzeniek, N Kahwaji, S Schlickeiser, P Reinke, S Geißler, HD Volk, ... Biomaterials, 121971, 2023 | 5 | 2023 |
| Editorial comment: variables affecting the presence of mesenchymal stromal cells in the peripheral blood and their relationship with apheresis product G Moll, N Drzeniek, J Kamhieh‐Milz, S Geissler, P Reinke British Journal of Haematology 189, 593-596, 2020 | 5 | 2020 |
| In Vitro Transcribed mRNA Immunogenicity Induces Chemokine‐Mediated Lymphocyte Recruitment and Can Be Gradually Tailored by Uridine Modification NM Drzeniek, N Kahwaji, S Picht, IM Dimitriou, S Schlickeiser, ... Advanced Science, 2308447, 2024 | | 2024 |
| Next Generation Mesenchymal Stromal Cells for Regenerative Purposes-Manipulation of the Cellular Phenotype Using Biomaterials and Non-viral Gene Transfer NM Drzeniek | | 2024 |
| Immuno-engineered MRNA Technology For Cell Engineering With Minimal Footprint NM Drzeniek, N Kahwaji, S Schlickeiser, P Reinke, S Geissler, HD Volk, ... TISSUE ENGINEERING PART A 29 (9-10), 2023 | | 2023 |
| Interactions Of Cell Adhesion, Cell-cell Contacts And MRNA Transfection In A Multimodal Bioinstructive Hydrogel NM Drzeniek, N Kahwaji, S Schlickeiser, CH Bucher, P Reinke, S Geissler, ... TISSUE ENGINEERING PART A 29 (9-10), 2023 | | 2023 |
| Mesenchymal Stem/Stromal Cells: NEXT-GENERATION MESENCHYMAL STROMAL/STEM CELL THERAPEUTICS: HIGH-END PHENOTYPIC, AND FUNCTIONAL PROFILING OF THERAPEUTIC PLACENTA-DERIVED PLX … G Moll, S Schlickeiser, K Juerchott, N Souidi, C Consentius, K Juelke, ... Cytotherapy 25 (6), S75, 2023 | | 2023 |
Sven GeißlerBIH Center for Regenerative Therapies, Charite Universitätsmedizin BerlinDirección de correo verificada de charite.de
